In the future, subcutaneous WAT harvested from human tissue biopsies may be first treated with ST32da and then expanded and induced to differentiate into brown adipocytes before their implantation as an autologous transplantation, thus enhancing the energy expenditure and improving glucose metabolism and insulin resistance in patients with obesity. Here, INS is linked to obesity disorder.